Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04170062 · ClinicalTrials.gov registry record · NA
Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest
A NA study of Pulmonary Disease, Chronic Obstructive and Dyspnea, sponsored by Johns Hopkins University.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 2
- Study locations
NCT04170062: Completed NA study of Pulmonary Disease, Chronic Obstructive and Dyspnea, sponsored by Johns Hopkins University.
NCT04170062 is a NA study of Pulmonary Disease, Chronic Obstructive and Dyspnea that has completed, run by Johns Hopkins University. The registered enrollment target is 11 participants, below the 1,044-participant average among 74 other Pulmonary Disease, Chronic Obstructive trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04170062, a NA study of Pulmonary Disease, Chronic Obstructive and Dyspnea, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is meant to compare the amount of oxygen required for hypoxemia relief between current standard of care (oxygen only) and oxygen with the addition of high flow air for Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease (ILD), and Pulmonary Hypertension (PH) patients during rest. Subjects will be titrated from 0 L/min until they maintain 95% SpO2 for each of the following delivery methods: 1. Pulses of pure oxygen (control) 2. Constant high flow air with pulses of pure oxygen 3. Out of phase pulses of high flow air and pure oxygen
Primary Outcome
This will be assessed using the difference between the oxygen delivery systems (pure oxygen and mixed high-flow air with oxygen) in the L/min flow of oxygen required for a participant to reach steady state at greater than or equal to 95% pulse oxygenation.
Conditions Studied
Interventions
- DEVICE Nasal Delivery of High-Flow Air and Oxygen Therapy
- DEVICE Nasal Delivery of Oxygen Therapy
Study Locations (2)
Maryland
- The Johns Hopkins Hospital - Baltimore
- Johns Hopkins Hospital Bayview Asthma and Allergy Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2020-12-15 |
| Est. Completion | 2024-12-16 |
| Phase | NA |
What the finished NCT04170062 record still lists
NCT04170062 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,044-participant average among 74 other Pulmonary Disease, Chronic Obstructive trials with a reported enrollment target (99% lower).
The record links to 6 conditions, with Pulmonary Disease, Chronic Obstructive appearing as the primary indexed condition, and to 2 interventions - of which Nasal Delivery of High-Flow Air and Oxygen Therapy is the first listed.
NCT04170062 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT04170062 about?
NCT04170062 is a clinical study titled "Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest". This study is meant to compare the amount of oxygen required for hypoxemia relief between current standard of care (oxygen only) and oxygen with the addition of high flow air for Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease (ILD), and Pulmonary Hypertension (PH) patients d...
What is the current status of trial NCT04170062?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2020-12-15. Estimated completion is 2024-12-16.
What conditions does trial NCT04170062 study?
This clinical trial studies the following conditions: Pulmonary Disease, Chronic Obstructive, Dyspnea, Pulmonary Fibrosis, Hypoxemia, Lung Diseases, Interstitial.
What interventions are being tested in trial NCT04170062?
The interventions under investigation include: Nasal Delivery of High-Flow Air and Oxygen Therapy (DEVICE), Nasal Delivery of Oxygen Therapy (DEVICE).
Who is sponsoring clinical trial NCT04170062?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04170062 being conducted?
This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Disease, Chronic Obstructive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04170062's enrollment target sits among peer trials
11 72nd of 74 higher than 3 of 74 other Pulmonary Disease, Chronic Obstructive trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Disease, Chronic Obstructive trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pragmatic Trial to Enhance Quality Safety, and Patient Experience in COPD
RECRUITING · NA
-
Air Filtration for COPD in VA Population of Veterans
ACTIVE NOT RECRUITING · NA
-
Evaluating the Clinical Effectiveness of a Patient-specific Silicone Stent
ACTIVE NOT RECRUITING · NA
-
Outlook: An Intervention to Improve Quality of Life in Serious Illness
COMPLETED · NA
-
Problem-Solving Therapy for People With Major Depression and Chronic Obstructive Pulmonary Disease
COMPLETED · NA
-
Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI